The Effects of Combination Treatment Using Phenoxodiol and Docetaxel, and Phenoxodiol and Secreted Frizzled-related Protein 4 on Prostate Cancer Cell Lines

Although much progress has been made for the treatment of prostate cancer, patients with advanced prostate cancer still have a poor 5 year survival rate. Current practices for hormone-refractory/castrate resistant, metastatic prostate cancer involve the use of taxanes. Docetaxel, in particular, is b...

Full description

Bibliographic Details
Main Authors: Mahoney, S., Arfuso, Frank, Millward, M., Dharmarajan, Arunasalam
Format: Journal Article
Published: OMICS Publishing Group 2014
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/37841